153 related articles for article (PubMed ID: 7059976)
1. Retardation and promotion of growth of spontaneously appearing tumors using immune lymphocytes previously exposed to embryonic antigens.
Gorczynski RM; MacRae S
Cancer Res; 1982 Mar; 42(3):784-90. PubMed ID: 7059976
[TBL] [Abstract][Full Text] [Related]
2. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
Blair PB; Lane MA; Yagi MJ
J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
[No Abstract] [Full Text] [Related]
3. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.
Blazar BA; Laing CA; Miller FR; Heppner GH
J Natl Cancer Inst; 1980 Aug; 65(2):405-10. PubMed ID: 6931258
[TBL] [Abstract][Full Text] [Related]
4. A time factor in the success or failure of immune rejection of transplanted tumors.
Vaage J
Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice.
Vaage J; Pepin KG
J Natl Cancer Inst; 1983 Jul; 71(1):147-55. PubMed ID: 6345879
[TBL] [Abstract][Full Text] [Related]
6. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
Blazar BA; Miller FR; Heppner GH
J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
[TBL] [Abstract][Full Text] [Related]
7. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
Morton DL; Goldman L; Wood DA
J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
[No Abstract] [Full Text] [Related]
8. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials.
Lopez DM; Paul RD
J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565
[No Abstract] [Full Text] [Related]
9. In vitro studies on splenocyte cytotoxicity against syngeneic mammary carcinomas of mice. 1. Reactivity of splenocytes from mice bearing mammary tumors against the corresponding and against other neoplasms.
More R; Yron I; Weiss DW
Isr J Med Sci; 1978 Jan; 14(1):146-61. PubMed ID: 204609
[No Abstract] [Full Text] [Related]
10. [Cytotoxic antibodies against tumor cells in the blood of intact C3H mice].
Lavrovskiĭ VA; Viksler VKh; Ustinov AS
Biull Eksp Biol Med; 1979 May; 87(5):460-2. PubMed ID: 222378
[TBL] [Abstract][Full Text] [Related]
11. Autoreactivity developing spontaneously in cultured mouse spleen cells. I. Evidence that cytotoxicity is directed against embryo-associated antigen.
Gorczynski RM
Immunology; 1976 Oct; 31(4):607-14. PubMed ID: 977034
[TBL] [Abstract][Full Text] [Related]
12. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
Vaage J
Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
[TBL] [Abstract][Full Text] [Related]
13. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
Arkhipov SA; Iunker VM; Gruntenko EV
Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
[TBL] [Abstract][Full Text] [Related]
14. Serum factors in mammary neoplasia: enhancement and antagonism of spleen cell activity in vitro detected by different methods of serum factor assay.
Blair PB; Lane MA
J Immunol; 1974 Feb; 112(2):439-53. PubMed ID: 4813898
[No Abstract] [Full Text] [Related]
15. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
16. [Splenocyte functional activity in mice growing the syngeneic transplantable hepatoma 22a].
Kiseleva EP; Malygin AM
Tsitologiia; 1984 Dec; 26(12):1409-15. PubMed ID: 6335612
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.
Lord EM
Br J Cancer Suppl; 1980 Apr; 4():123-7. PubMed ID: 6932915
[TBL] [Abstract][Full Text] [Related]
18. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.
Vaage J; Pepin KG
Cancer Res; 1985 Feb; 45(2):659-66. PubMed ID: 3967241
[TBL] [Abstract][Full Text] [Related]
19. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
Fisher B; Wolmark N; Saffer EA
J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
[TBL] [Abstract][Full Text] [Related]
20. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
Vaage J; Agarwal S
Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
